SC 13G

Company

Pelthos Therapeutics Inc.

Filed

March 4, 2024

Accession Number

0001753926-24-000459

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →